Similar articles

• Paliperidone ER and oral risperidone in patients with schizophrenia: a comparative database analysis.

  Turkoz I, Bossie CA, Lindenmayer JP, Schooler N, Canuso CM. Turkoz I, et al. BMC Psychiatry. 2011 Feb 7;11:21. doi: 10.1186/1471-244X-11-21. BMC Psychiatry. 2011. PMID: 21299844 Free PMC article.
• Paliperidone for treatment of schizophrenia.

  Nussbaum AM, Stroup TS. Nussbaum AM, et al. Schizophr Bull. 2008 May;34(3):419-22. doi: 10.1093/schbul/sbn015. Epub 2008 Mar 28. Schizophr Bull. 2008. PMID: 18375569 Free PMC article. Review.
• Changes in plasma concentrations of risperidone and 9-hydroxyrisperidone and the associated clinical effects during the switch from oral risperidone to extended-release paliperidone tablets in patients with schizophrenia.

  Yang DS, Seong SJ, Yoon YR, Lim MS, Kwak KH, Lee SJ. Yang DS, et al. J Psychopharmacol. 2014 Apr;28(4):341-8. doi: 10.1177/0269881113516203. Epub 2013 Dec 17. J Psychopharmacol. 2014. PMID: 24346811 Clinical Trial.
• [Paliperidone, risperidone].

  Takeuchi K, Sanjo K, Sakai A. Takeuchi K, et al. Nihon Rinsho. 2013 Apr;71(4):654-9. Nihon Rinsho. 2013. PMID: 23678595 Review. Japanese.
• Paliperidone ER versus risperidone for neurocognitive function in patients with schizophrenia: a randomized, open-label, controlled trial.

  Kim SW, Chung YC, Lee YH, Lee JH, Kim SY, Bae KY, Kim JM, Shin IS, Yoon JS. Kim SW, et al. Int Clin Psychopharmacol. 2012 Sep;27(5):267-74. doi: 10.1097/YIC.0b013e328356acad. Int Clin Psychopharmacol. 2012. PMID: 22809972 Clinical Trial.